February 11, 2012

CONNECT

TECHNOLOGY TED ENGADGET TECHCRUNCH JOYSTIQ SOCIAL MEDIA APPLE BLOG CRUNCHBASE WOMEN IN TECH MOBILE

Breast Cancer Nanotech: Lorenzo Berti Developing New Particles To Fight Tumors

First Posted: 8/2/10 Updated: 5/25/11

React

Inspiring
Funny
Obsolete
Scary
Must-Have
Amazing
Innovative
Nerdy

Breast Cancer , Lorenzo Berti , Susan G. Komen For The Cure , Breast Cancer Nanotechnology , Nanotechnology , Technology News

share this story

Get Technology Alerts

Submit this story

McClatchy:

Tiny cancer-fighting agents are poised to play a big role in the future of chemotherapy.

The breast cancer foundation Susan G. Komen for the Cure has awarded a UC Davis researcher $450,000 for the development of nanoparticles capable of effectively targeting and destroying tumor cells while leaving healthy cells unharmed.

Read the whole story: McClatchy

FOLLOW HUFFPOST TECH

Facebook:

45k

Twitter:

Get Alerts

CONTRIBUTE

TO THIS STORY

Related News On Huffington Post:

Read more from Huffington Post bloggers:

Chris Glorioso: Austerity Bites

There is a false dichotomy buried in the austerity vs. stimulus policy debate. Both sides share the notion that the road to economic recovery is forked, and that we must choose only one path.

Richard Grenell: Not Just Surviving Cancer, but Thriving in It

Cancer taught my family that my mom is much stronger than we ever thought. Faced with a devastating diagnosis, she just kept going and living -- never complaining. And in the process, she proved she isn't just a cancer survivor.

Amy Boesky: Seize the Day: Support Breast and Ovarian Cancer Survivors and 'Previvors'

Carpe diem--Latin for "seize the day." This grab-life-while-you-can ethos has particular importance for those of us whose families carry genetic mutations for breast and ovarian cancers.

Wayne Pacelle: Replacing the "Guinea Pig:" Safer, Humane Chemical Tests

Animal tests are expensive and time consuming, and their relevance is often questioned by stakeholders on one side or the other, leading to disputes over which chemicals represent a real threat.